Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 08, 2016 07:30 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Present at Upcoming September Conferences

BASKING RIDGE, N.J., Sept. 08, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development...
September 06, 2016 07:30 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences Completes Enrollment of First Patient Cohort in Phase 2 Trial of CLBS03 to Treat Type 1 Diabetes

BASKING RIDGE, N.J., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences (NASDAQ:CLBS), (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development and...
August 09, 2016 16:08 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences Reports 2016 Second Quarter Financial Results

Total Quarterly Revenues Increase 41% and Expenses Decrease 50% versus Prior Year Conference Call Begins Today at 5:00 pm Eastern Time BASKING RIDGE, N.J., Aug. 09, 2016 (GLOBE NEWSWIRE) -- ...
August 02, 2016 07:30 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Host 2016 Second Quarter Financial Results Conference Call on August 9 at 5:00 pm Eastern Time

BASKING RIDGE, N.J., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development...
July 28, 2016 07:30 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences Receives FDA Fast Track Designation for CLBS03 to Treat Recent Onset Type 1 Diabetes

BASKING RIDGE, N.J., July 28, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development...
July 27, 2016 09:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences Announces 1-for-10 Reverse Split

BASKING RIDGE, N.J., July 27, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development...
July 07, 2016 07:30 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Present at Upcoming July Conferences

BASKING RIDGE, N.J., July 07, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development...
June 27, 2016 07:30 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences SVP and President of PCT, Robert Preti, PhD, Named Chairman of the Alliance for Regenerative Medicine

NEW YORK, June 27, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences (Nasdaq:CLBS), a cell therapy company combining an industry-leading development and manufacturing services provider (PCT, LLC,...
June 21, 2016 01:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Subsidiary, PCT, to Manufacture Phase 3 Cell Therapy Product for Kiadis Pharma

BASKING RIDGE, N.J., June 21, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development...
June 01, 2016 07:30 ET | Source: Lisata Therapeutics

Caladrius Biosciences to Present at Upcoming June Conferences

BASKING RIDGE, N.J., June 01, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development...